Skip to Content
Contact Form Map & Directions Videos

Author: Brenda Fulmer

Levaquin Blamed for Neuropathy, and Other Serious Side Effects

03/30/2015
Articles
BY

A reported 100,000 Americans, including a 54-year-old Illinois man and 36-year-old North Carolina woman, have reported severe side effects from Levaquin, an antibiotic that packs enough pill power to kill anthrax. Levaquin, a drug classified in the fluoroquinolone family, is now undergoing another Food and Drug Administration evaluation because of the controversy. Twelve […]

Read More

Lengthy Clinical Trial Process Gets Overhaul by FDA

03/10/2015
Articles
BY

Safeguarding, streamlining, strengthening the clinical trial process is one of three of the Food and Drug Administration’s primary goals for 2015. So states an 11-page document titled 2014 – 2015 Strategic Priorities. The other two goals focus on 1) striking a better balance between data collection requirements and the time […]

Read More

“Big Pharma’s” Resistance To Go Mobile Multifaceted

12/16/2014
Articles
BY

The reasons the seemingly cutting-edge pharmaceutical industry lags behind in the mobile-application domain are far and wide, say medical marketers, who predict that, in the end, companies’ bottom lines, doctors’ choices and patient health will suffer. Let’s look at the facts: First, one-third of drug-makers’ Web sites are optimized for […]

Read More

Hear What Our Clients Have To Say

"Cannot say enough about Mr. Ward and his team. Joanna and Mr. Ward helped me through a very difficult time while being extremely professional and prompt. I would highly recommend."
Posted By: Samantha Saundry